» Articles » PMID: 31268670

Nanoparticle-Aided Characterization of Arterial Endothelial Architecture During Atherosclerosis Progression and Metabolic Therapy

Abstract

Atherosclerosis is associated with a compromised endothelial barrier, facilitating the accumulation of immune cells and macromolecules in atherosclerotic lesions. In this study, we investigate endothelial barrier integrity and the enhanced permeability and retention (EPR) effect during atherosclerosis progression and therapy in mice using hyaluronan nanoparticles (HA-NPs). Utilizing ultrastructural and plaque imaging, we uncover a significantly decreased junction continuity in the atherosclerotic plaque-covering endothelium compared to the normal vessel wall, indicative of disrupted endothelial barrier. Intriguingly, the plaque advancement had a positive effect on junction stabilization, which correlated with a 3-fold lower accumulation of administrated HA-NPs in advanced plaques compared to early counterparts. Furthermore, by using super-resolution and correlative light and electron microscopy, we trace nanoparticles in the plaque microenvironment. We find nanoparticle-enriched endothelial junctions, containing 75% of detected HA-NPs, and a high HA-NP accumulation in the endothelium-underlying extracellular matrix, which suggest an endothelial junctional traffic of HA-NPs to the plague. Finally, we probe the EPR effect by HA-NPs in the context of metabolic therapy with a glycolysis inhibitor, 3PO, proposed as a vascular normalizing strategy. The observed trend of attenuated HA-NP uptake in aortas of 3PO-treated mice coincides with the endothelial silencing activity of 3PO, demonstrated Interestingly, the therapy also reduced the plaque inflammatory burden, while activating macrophage metabolism. Our findings shed light on natural limitations of nanoparticle accumulation in atherosclerotic plaques and provide mechanistic insight into nanoparticle trafficking across the atherosclerotic endothelium. Furthermore, our data contribute to the rising field of endothelial barrier modulation in atherosclerosis.

Citing Articles

High-Density Lipoprotein Biomimetic Inorganic-Organic Composite Nanosystem for Atherosclerosis Therapy.

Zhang Y, Liu D, Wang Y, Sun Q, Mei D, Wang X Polymers (Basel). 2025; 17(5).

PMID: 40076117 PMC: 11902788. DOI: 10.3390/polym17050625.


Dual-mode-driven nanomotors targeting inflammatory macrophages for the MRI and synergistic treatment of atherosclerosis.

Wei M, Jiang Q, Bian S, Chang P, Li B, Shi C J Nanobiotechnology. 2025; 23(1):54.

PMID: 39881324 PMC: 11776285. DOI: 10.1186/s12951-025-03136-0.


Platelet membrane decorated exosomes enhance targeting efficacy and therapeutic index to alleviate arterial restenosis.

Lu S, Wang R, Cai M, Yuan C, Gao B, Guo D Theranostics. 2025; 15(2):408-427.

PMID: 39744678 PMC: 11671393. DOI: 10.7150/thno.103747.


Glucose Metabolism Reprogramming of Vascular Endothelial Cells and Its Implication in Development of Atherosclerosis.

Luo S, Li L, Chen H, Wei J, Yang D Rev Cardiovasc Med. 2024; 25(11):423.

PMID: 39618869 PMC: 11607510. DOI: 10.31083/j.rcm2511423.


Nanoparticles as a Novel Platform for Cardiovascular Disease Diagnosis and Therapy.

Tang C, Zhou K, Wu D, Zhu H Int J Nanomedicine. 2024; 19:8831-8846.

PMID: 39220195 PMC: 11365508. DOI: 10.2147/IJN.S474888.


References
1.
Rademakers T, Douma K, Hackeng T, Post M, Sluimer J, Daemen M . Plaque-associated vasa vasorum in aged apolipoprotein E-deficient mice exhibit proatherogenic functional features in vivo. Arterioscler Thromb Vasc Biol. 2012; 33(2):249-56. DOI: 10.1161/ATVBAHA.112.300087. View

2.
Huang G, Huang H . Application of hyaluronic acid as carriers in drug delivery. Drug Deliv. 2018; 25(1):766-772. PMC: 6058522. DOI: 10.1080/10717544.2018.1450910. View

3.
Rudd J, Myers K, Bansilal S, Machac J, Pinto C, Tong C . Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008; 49(6):871-8. DOI: 10.2967/jnumed.107.050294. View

4.
Malinova T, Huveneers S . Sensing of Cytoskeletal Forces by Asymmetric Adherens Junctions. Trends Cell Biol. 2017; 28(4):328-341. DOI: 10.1016/j.tcb.2017.11.002. View

5.
Angelini D, Hyun S, Grigoryev D, Garg P, Gong P, Singh I . TNF-alpha increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia. Am J Physiol Lung Cell Mol Physiol. 2006; 291(6):L1232-45. DOI: 10.1152/ajplung.00109.2006. View